Diabetes mellitus—Progress and opportunities in the evolving epidemic
Cell · 2024-07 · 187 (15) · 3789-3820
DOI: 10.1016/j.cell.2024.06.029 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell, 2024-07. Verfasst von E Dale Abel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Electronic address: domchair_daleabel@mednet…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 316-mal zitiert (Crossref) und nennt 305 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, AHRQ HHS, BLRD VA.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes, a complex multisystem metabolic disorder characterized by hyperglycemia, leads to complications that reduce quality of life and increase mortality. Diabetes pathophysiology includes dysfunction of beta cells, adipose tissue, skeletal muscle, and liver. Type 1 diabetes (T1D) results from immune-mediated beta cell destruction. The more prevalent type 2 diabetes (T2D) is a heterogeneous disorder characterized by varying degrees of beta cell dysfunction in concert with insulin resistance. The strong association between obesity and T2D involves pathways regulated by the central nervous system governing food intake and energy expenditure, integrating inputs from peripheral organs and the environment. The risk of developing diabetes or its complications represents interactions between genetic susceptibility and environmental factors, including the availability of nutritious food and other social determinants of health. This perspective reviews recent advances in understanding the pathophysiology and treatment of diabetes and its complications, which could alter the course of this prevalent disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. Electronic address: domchair_daleabel@mednet.ucla.edu.
- Department of Pediatrics, Division of Endocrinology & Diabetes, Department of Genetics, Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
- Division of Endocrinology, Diabetes and Metabolism, The Ohio State University College of Medicine, Columbus, OH, USA.
- Department of Metabolism, Digestion and Reproduction, Imperial College London, and Imperial College NHS Trust, London, UK.
- Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Förderung
- NIDDK NIH HHS
- AHRQ HHS
- BLRD VA
- Wellcome Trust
- NHLBI NIH HHS
- JDRF
- American Heart Association
- NIHR Imperial Biomedical Research Centre
Zitieren
APA
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024). Diabetes mellitus—Progress and opportunities in the evolving epidemic. Cell, 187(15), 3789-3820. https://doi.org/10.1016/j.cell.2024.06.029
Vancouver
Abel ED, Gloyn AL, Evans-Molina C, Joseph JJ, Misra S, Pajvani UB, et al. Diabetes mellitus—Progress and opportunities in the evolving epidemic. Cell. 2024;187(15):3789-3820. doi:10.1016/j.cell.2024.06.029
BibTeX
@article{Abel2024,
author = {Abel, E Dale and Gloyn, Anna L and Evans-Molina, Carmella and Joseph, Joshua J and Misra, Shivani and Pajvani, Utpal B and Simcox, Judith and Susztak, Katalin and Drucker, Daniel J},
title = {Diabetes mellitus—Progress and opportunities in the evolving epidemic},
journal = {Cell},
year = {2024},
volume = {187},
number = {15},
pages = {3789--3820},
doi = {10.1016/j.cell.2024.06.029}
}
EUVIMED